AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Medpace Holdings, Inc.
Video analysis: MEDP
All videosNo video analysis for this stock yet. Request one from our team.
News: MEDP
CON vs. MEDP: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical Services sector have probably already heard of Concentra Group (CON) and Medpace (MEDP). But which of these two stocks is more attractive to value investors?
Why Medpace (MEDP) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
American Capital Management Inc. Invests $111.33 Million in Medpace Holdings, Inc. $MEDP
American Capital Management Inc. bought a new stake in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund bought 210,217 shares of the company's stock, valued at approximately $111,329,000. Medpace makes up about 5.0%
Medpace Stock Hovers Near Entry, Offers Second Chance After July Spike
Medpace stock is back below a buy point of 628.92. The medical research contractor delivered an earnings beat for its second quarter.
CON vs. MEDP: Which Stock Should Value Investors Buy Now?
Investors with an interest in Medical Services stocks have likely encountered both Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?
What Investors Should Know About Medpace CEO Troendle Selling $10 Million in Stock
The CEO sold 15,978 shares at a weighted-average price of $623.93 over two trading days ending Aug. 24, 2026. The transaction involved shares equal to 3% of Troendle's direct equity holdings and 0.3% of his total combined stake.
Bank of New York Mellon Corp Takes Position in Medpace Holdings, Inc. $MEDP
Bank of New York Mellon Corp bought a new stake in Medpace Holdings, Inc. (NASDAQ: MEDP) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 146,588 shares of the company's stock, valued at approximately $77,632,000. Bank of
B. Metzler seel. Sohn & Co. AG Invests $4.74 Million in Medpace Holdings, Inc. $MEDP
B. Metzler seel. Sohn and Co. AG purchased a new stake in shares of Medpace Holdings, Inc. (NASDAQ: MEDP) in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 8,944 shares of the company's stock, valued at approximately $4,737,000. Several other
Similar companies
-
Illumina, Inc.
ILMN
·
NASDAQ
Compare
-
ICON Public Limited Company
ICLR
·
NASDAQ
Compare
-
Waters Corporation
WAT
·
New York Stock Exchange
Compare
-
Centene Corp.
CNC
·
New York Stock Exchange
Compare
-
Smith & Nephew plc
SNN
·
New York Stock Exchange
Compare
-
Quest Diagnostics Incorporated
DGX
·
New York Stock Exchange
Compare